Trial Profile
Optimal rhCG(Ovidrel (R)) Dose for Final Oocyte Maturation Triggering in Poor Responder During IVF and ICSI Cycles
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Choriogonadotropin alfa (Primary)
- Indications Infertility
- Focus Therapeutic Use
- 11 Apr 2013 Planned End Date changed from 1 Dec 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 04 Aug 2011 New trial record